Djokovic washes his image with the purchase of the Danish pharmaceutical company QuantBioRes

The Serbian tennis player Novak Djokovic has acquired 80% of the capital of the Danish pharmaceutical company QuantBioRes, a company that is investigating a medical treatment against Covid-19, just a few days after the end of his controversial stay in Australia for the Grand Slam, at the that the Australian Government ended by canceling his visa due to alleged irregularities in his documentation to access ‘aussie’ territory. An operation that has surprised the world of sport, especially after being repatriated for not meeting the vaccination requirements, But it is more than a year old. As confirmed by the CEO of the biotech company, Ivan Loncarevic, to this medium, “the company was founded in June 2020 and Djokovic was one of the founders, he was always there.”

The biotech company, he says, had legal advice to settle in Denmark and was very meticulous in that regard. “We have carried out the process with total transparency,in accordance with the law and leaving the percentages very clear”Loncarevic says. The company, as specified on its website, uses an innovative technology called ‘Resonant Recognition Model’ (RRM for its acronym in English). “We spend time and resources to accurately predict the chemical and physical properties of molecules, which can be useful in many fields of science, especially in medicine,” says QuantBioRes.

The team, made up of twenty scientists including biologists, engineers, programmers and university professors, as Loncarevic explains, highlights the value of its “technology” and aspires to extend it to other viruses. They also hope to obtain results from the development of their treatment against the Covid infection mechanism shortly, after completing the tests on animals. “We hope that in the summer of 2022 we will have some conclusions, and we are very positive,” says the CEO. Before testing advances in medicinal treatment with humans, they will begin to contrast their biological development in different animals, such as hamsters and chickens.

The CEO has not wanted to reveal how much money was spent to start the company but has stated that what really gives value to the project is the innovative formula of the RRM. His contribution to science would be of great value, as he clarifies, since it is a new method to cure resistant viruses and bacteria. As the company’s website itself explains, it is a “biophysical model” that analyzes the biological interaction of the protein in order to “predict mutations and design molecules with desired function”.

This inversion of the number one in the world ranking has emerged just a few days after the tennis player from Belgrade had to leave Australia, through a judicial decision. After listening to the Government of the country and to ‘Nole’ himself in a process broadcast on YouTube, the three judges of the Australian Federal Court decided to give green light to cancel your entry permit, not being vaccinated against Covid-19, as required by their access laws.

In this way, Djokovic ended up leaving Australian territory last Sunday for Dubai, making him unable to defend the title of champion of the first major tournament on the 2022 tennis circuit, which also he has been champion nine times.

Source: LA INFORMACIÓN – Lo último by

*The article has been translated based on the content of LA INFORMACIÓN – Lo último by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!